Mysore Petro Chemicals Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Mysore Petro Chemicals Ltd is ₹ 79.79 as of 23 Mar 15:30 . The P/E Ratio of Mysore Petro Chemicals Ltd changed from 2.1 on March 2022 to 26.9 on March 2025 . This represents a CAGR of 89.18% over 4 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 years The Market Cap of Mysore Petro Chemicals Ltd changed from ₹ 49.44 crore on March 2021 to ₹ 81.67 crore on March 2025 . This represents a CAGR of 10.56% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 years The revenue of Mysore Petro Chemicals Ltd for the Dec '25 is ₹ 20.27 crore as compare to the Sep '25 revenue of ₹ 6.78 crore. This represent the growth of 198.97% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of Mysore Petro Chemicals Ltd for the Dec '25 is ₹ -2.31 crore as compare to the Sep '25 ebitda of ₹ -0.09 crore. This represent the growth of 2466% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of Mysore Petro Chemicals Ltd changed from ₹ 8.75 crore to ₹ -1.91 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The Dividend Payout of Mysore Petro Chemicals Ltd changed from -129 % on March 2021 to -17.21 % on March 2025 . This represents a CAGR of -33.18% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .

About Mysore Petro Chemicals Ltd

Mysore Petro Chemicals Ltd (MPCL), a public limited company promoted by H P Dhanuka in 1976, manufactures Phthalic Anhydride (PA) and Maleic Anhydride (MA) from its plant at Raichur, Karnataka (12000 tpa capacity) and Taloja Maharashtra (5400 mt capacity) respectively. Presently, the Company is engaged in the trading of Orthoxylene, Phthalic Anhydride, Maleic Anhydride, Benzoic Acid and other petrochemical products. MPCL has diversified into the manufacture of maleic anhydride at its plant at Taloja, New Bombay, with a capacity of 45,000 tpa, in technical and financial collaboration with Lurgi, Germany.
MPCL promoted a new company, I G Petrochemicals, a 100% EOU, in collaboration with Lurgi, Germany to produce Pathalic Anhydride. The commercial production of Phthalic Anhydride (PA)-2 of IGPL plant commenced during 1999-2000.

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

FAQs for the comparison of Mysore Petro Chemicals Ltd and Tatva Chintan Pharma Chem Ltd

Which company has a larger market capitalization, Mysore Petro Chemicals Ltd or Tatva Chintan Pharma Chem Ltd?

Market cap of Mysore Petro Chemicals Ltd is 52 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,619 Cr

What are the key factors driving the stock performance of Mysore Petro Chemicals Ltd and Tatva Chintan Pharma Chem Ltd?

The stock performance of Mysore Petro Chemicals Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mysore Petro Chemicals Ltd and Tatva Chintan Pharma Chem Ltd?

As of March 23, 2026, the Mysore Petro Chemicals Ltd stock price is INR ₹79.79. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1119.65.

How do dividend payouts of Mysore Petro Chemicals Ltd and Tatva Chintan Pharma Chem Ltd compare?

To compare the dividend payouts of Mysore Petro Chemicals Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.